A$0.62 -0.0 -3.1%
Last Trade - 2:21am
| Market Cap | £78.1m |
| Enterprise Value | £106.2m |
| Revenue | £67.1m |
| Position in Universe | 717th / 1844 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 54.1 | 98.0 | 106.6 | 111.7 | 118.3 | 127.3 | 133.7 | |||
| +137.6 | -27.8 | -15.1 | +22.0 | +46.7 | +33.3 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Apiam Animal Health Limited is a provider of veterinary products and services to production and companion animals. The Company services production animals throughout their life cycle, including the provision of genetics, veterinary services, wholesale and retail of related products, and technical services related to food-chain security. It provides systems to assist in herd health programs; production advice; consulting services and products to assist in the prevention of animal diseases; technologies to manage compliance with legislative requirements on pharmaceutical use; advice and services in respect of animal welfare compliance; retail animal health product sales; on-farm delivery of products via its own logistics capability; third party auditing services of industry quality assurance programs; technology development for animal health management; ancillary services, such as sales and delivery of genetics-associated products, and on-farm and online training programs for clients.
| Last Annual | June 30th, 2020 |
| Last Interim | June 30th, 2020 |
| Incorporated | March 25, 2015 |
| Public Since | December 15, 2015 |
| No. of Shareholders: | 1,203 |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 215,072,709 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | East Bendigo 27-33 Piper Lane, BENDIGO, 3550, Australia |
| Web | http://www.apiam.com.au |
| Phone | +61 3 54455999 |
| Contact | () |
| Auditors | Grant Thornton Audit Pty Ltd |
As of 2:21am, shares in Apiam Animal Health are trading at A$0.62, giving the company a market capitalisation of £78.1m. This share price information is delayed by 15 minutes.
Shares in Apiam Animal Health are currently trading at A$0.62 and the price has moved by 39.13% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Apiam Animal Health price has moved by 41.91% over the past year.
Of the analysts with advisory recommendations for Apiam Animal Health, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Apiam Animal Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Apiam Animal Health is scheduled to issue upcoming financial results on the following dates:
The Apiam Animal Health dividend yield is 3.13% based on the trailing twelve month period.
Last year, Apiam Animal Health paid a total dividend of 0.02, and it currently has a trailing dividend yield of 3.13%. Looking ahead, Apiam Animal Health has not announced an ex-dividend date yet.
Apiam Animal Health has yet to annouce their ex-dividend date. The historic dividend yield on Apiam Animal Health shares is currently 3.13%.
To buy shares in Apiam Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Apiam Animal Health are currently trading at A$0.62, giving the company a market capitalisation of £78.1m.
Here are the trading details for Apiam Animal Health:
Based on an overall assessment of its quality, value and momentum, Apiam Animal Health is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Apiam Animal Health are currently priced at A$0.62. At that level they are trading at 23.44% discount to the analyst consensus target price of 0.00.
Analysts covering Apiam Animal Health currently have a consensus Earnings Per Share (EPS) forecast of 0.06 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apiam Animal Health. Over the past six months, the relative strength of its shares against the market has been 13.38%. At the current price of A$0.62, shares in Apiam Animal Health are trading at 17.05% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Apiam Animal Health PE ratio based on its reported earnings over the past 12 months is 15.65. The shares are currently trading at A$0.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We were unable to find the directors for Apiam Animal Health.
Here are the top five shareholders of Apiam Animal Health based on the size of their shareholding:
